Multiple immune cell subsets and immune mediators

Multiple immune cell subsets and immune mediators refers to the integrated network of specialized cells and signaling molecules that constitute the immune system. This includes various leukocyte lineages such as T lymphocytes, B lymphocytes, natural killer (NK) cells, and myeloid cells, as well as soluble factors like cytokines, chemokines, and complement proteins (Abbas et al., Cellular and Molecular Immunology, 2017). These components work in concert to protect the host from pathogens and malignancy while maintaining self-tolerance. In disease states, dysregulation of these subsets or mediators can lead to chronic inflammation, autoimmunity, or immune evasion by tumors (Pardoll, Nature Reviews Cancer, 2012). Therapeutic intervention often involves targeting specific nodes within this network, such as using monoclonal antibodies to neutralize cytokines or checkpoint inhibitors to reinvigorate exhausted T cells. Because this term encompasses a broad system rather than a single molecule, it is typically used to describe the overall immune landscape or microenvironment in clinical and research settings. Monitoring this system involves assessing cell frequencies and protein concentrations to gauge therapeutic response or toxicity (NCI, CTCAE v5.0, 2017). Understanding the synergy between these elements is essential for developing multi-targeted therapies and personalized medicine approaches.

Other names

Immune system componentsLeukocyte subsets and cytokinesImmune microenvironmentImmune landscape

Broad modulation of immune activity through the inhibition of cytokine signaling, depletion of specific leukocyte populations, or blockade of inhibitory receptors on immune cells (Abbas et al., 2017; Pardoll, 2012).